These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9436720)

  • 21. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin type A therapy for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003633. PubMed ID: 15674910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging study.
    Wohlfarth K; Schwandt I; Wegner F; Jürgens T; Gelbrich G; Wagner A; Bogdahn U; Schulte-Mattler W
    J Neurol; 2008 Dec; 255(12):1932-9. PubMed ID: 18854916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.
    Mordin M; Masaquel C; Abbott C; Copley-Merriman C
    BMJ Open; 2014 Oct; 4(10):e005150. PubMed ID: 25324317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term follow-up of botulinum toxin A in cervical dystonia.
    Mohammadi B; Buhr N; Bigalke H; Krampfl K; Dengler R; Kollewe K
    Neurol Res; 2009 Jun; 31(5):463-6. PubMed ID: 19278576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm.
    Nüssgens Z; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Safety and efficacy of the Relatox in the treatment of patients with cervical dystonia (results of a multicenter simple blind comparative randomized study)].
    Khatkova SE; Orlova OR; Pokhabov DV; Diagileva VP; Novikov SA; Pogoreltseva OA; Shevchenko VS; Nikolaev EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):80-85. PubMed ID: 36440782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)).
    Dressler D; Tacik P; Adib Saberi F
    J Neural Transm (Vienna); 2014 Jan; 121(1):29-31. PubMed ID: 23913131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia.
    Kazerooni R; Broadhead C
    Am J Health Syst Pharm; 2015 Feb; 72(4):301-7. PubMed ID: 25631837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
    Hyman N; Barnes M; Bhakta B; Cozens A; Bakheit M; Kreczy-Kleedorfer B; Poewe W; Wissel J; Bain P; Glickman S; Sayer A; Richardson A; Dott C
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):707-12. PubMed ID: 10811692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type A versus anticholinergics for cervical dystonia.
    Rodrigues FB; Duarte GS; Castelão M; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD004312. PubMed ID: 33852744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
    Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
    Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
    Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies.
    Hauser RA; Truong D; Hubble J; Coleman C; Beffy JL; Chang S; Picaut P
    J Neural Transm (Vienna); 2013 Feb; 120(2):299-307. PubMed ID: 22878514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.
    Han Y; Stevens AL; Dashtipour K; Hauser RA; Mari Z
    J Neurol; 2016 Apr; 263(4):772-80. PubMed ID: 26914922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.